The complex inertness of 99mTc-EHDP, -MDP, -PPi and -TriP was determined in vitro by means of protein binding of 99mTc after dilution in a phosphate-buffered albumin solution. Commercially available kits were used. In vitro, 99mTc- EHDP was found to be the most stable complex. The biodistribution of these agents was evaluated in the adult rat; here the less stable 99mTc-MDP proved to be the superior bone imaging agent. It is suggested that the complex inertness and the bone affinity are opposing properties of the 99mTc-phosphate compounds, because the complex must hydrolyse before the phosphate compound and technetium (IV) are deposited separately in bone. Hence, bone imaging with 99mTc-phosphate compounds demands a compromise concerning the stability of these complexes at low ligand concentrations, which among the investigated agents is best accomplished by 99mTc-MDP.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.